Senhwa Biosciences, Inc. (TPEX:6492)
Taiwan
· Delayed Price · Currency is TWD 36.95
+1.15 (3.21%)
Aug 15, 2025, 2:31 PM CST
Senhwa Biosciences Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 894.14 | 1,026 | 1,319 | 1,619 | 2,033 | 2,369 | Upgrade
|
| Cash & Short-Term Investments | 894.14 | 1,026 | 1,319 | 1,619 | 2,033 | 2,369 | Upgrade
|
| Cash Growth | -23.38% | -22.20% | -18.55% | -20.34% | -14.19% | 182.89% | Upgrade
|
| Accounts Receivable | - | - | - | - | 0.19 | - | Upgrade
|
| Other Receivables | 0.13 | 0.18 | 10.59 | 8.64 | 7 | 6.4 | Upgrade
|
| Receivables | 0.13 | 0.18 | 10.59 | 8.64 | 7.18 | 6.4 | Upgrade
|
| Prepaid Expenses | 6.39 | 8.69 | 6.74 | 5.51 | 1.62 | 3.38 | Upgrade
|
| Other Current Assets | - | - | - | 4.18 | 3.35 | 4.91 | Upgrade
|
| Total Current Assets | 900.66 | 1,035 | 1,336 | 1,637 | 2,045 | 2,383 | Upgrade
|
| Property, Plant & Equipment | 28.08 | 17.2 | 14.37 | 15.75 | 15.42 | 9.9 | Upgrade
|
| Long-Term Investments | 0 | 0 | 0.13 | 0.13 | 0.13 | 0.13 | Upgrade
|
| Other Intangible Assets | 0.09 | 0.14 | 0.23 | - | 0.07 | - | Upgrade
|
| Other Long-Term Assets | 14.88 | 13.78 | 12.46 | 1.54 | 1.32 | 1.88 | Upgrade
|
| Total Assets | 943.71 | 1,066 | 1,363 | 1,655 | 2,062 | 2,395 | Upgrade
|
| Accrued Expenses | - | 21.58 | 32.37 | 22.04 | 75.63 | 47.59 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | - | 7.2 | Upgrade
|
| Current Portion of Leases | 9.04 | 7.16 | 6.31 | 8.18 | 5.17 | 4.18 | Upgrade
|
| Current Income Taxes Payable | - | 0.14 | - | - | - | - | Upgrade
|
| Other Current Liabilities | 14.42 | 2.21 | 4.2 | 2.73 | 1.43 | 2.3 | Upgrade
|
| Total Current Liabilities | 23.47 | 31.09 | 42.89 | 32.95 | 82.23 | 61.27 | Upgrade
|
| Long-Term Debt | - | - | - | - | - | 2.06 | Upgrade
|
| Long-Term Leases | 17.18 | 7.84 | 3.29 | 7.98 | 10.21 | 5.67 | Upgrade
|
| Total Liabilities | 40.64 | 38.93 | 46.18 | 40.93 | 92.44 | 68.99 | Upgrade
|
| Common Stock | 897.04 | 897.44 | 897.44 | 897.44 | 897.44 | 896.58 | Upgrade
|
| Additional Paid-In Capital | 175.5 | 469.58 | 765.88 | 1,116 | 1,444 | 1,790 | Upgrade
|
| Retained Earnings | -118.88 | -293.87 | -296.31 | -349.63 | -329.26 | -354.88 | Upgrade
|
| Treasury Stock | -49.36 | -51.35 | -51.35 | -51.35 | -38.11 | -1.99 | Upgrade
|
| Comprehensive Income & Other | -1.22 | 5.24 | 1.49 | 1.35 | -5.24 | -3.39 | Upgrade
|
| Shareholders' Equity | 903.07 | 1,027 | 1,317 | 1,614 | 1,969 | 2,326 | Upgrade
|
| Total Liabilities & Equity | 943.71 | 1,066 | 1,363 | 1,655 | 2,062 | 2,395 | Upgrade
|
| Total Debt | 26.22 | 15 | 9.6 | 16.16 | 15.38 | 19.11 | Upgrade
|
| Net Cash (Debt) | 867.92 | 1,011 | 1,309 | 1,603 | 2,017 | 2,349 | Upgrade
|
| Net Cash Growth | -24.36% | -22.78% | -18.33% | -20.54% | -14.14% | 183.16% | Upgrade
|
| Net Cash Per Share | 9.74 | 11.34 | 14.68 | 17.97 | 22.50 | 29.75 | Upgrade
|
| Filing Date Shares Outstanding | 89.1 | 89.19 | 89.19 | 88.63 | 89.31 | 89.62 | Upgrade
|
| Total Common Shares Outstanding | 89.1 | 89.19 | 89.19 | 88.63 | 89.31 | 89.62 | Upgrade
|
| Working Capital | 877.19 | 1,004 | 1,293 | 1,605 | 1,963 | 2,322 | Upgrade
|
| Book Value Per Share | 10.14 | 11.52 | 14.77 | 18.21 | 22.05 | 25.96 | Upgrade
|
| Tangible Book Value | 902.98 | 1,027 | 1,317 | 1,614 | 1,969 | 2,326 | Upgrade
|
| Tangible Book Value Per Share | 10.13 | 11.51 | 14.77 | 18.21 | 22.05 | 25.96 | Upgrade
|
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.